Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Description

This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.

Conditions

Pancreatic Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Condition
Pancreatic Cancer
Intervention / Treatment

-

Contacts and Locations

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Jackson

University of Mississippi Medical Center, Jackson, Mississippi, United States, 39216

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults 18 years of age or older at time of signing informed consent
  • * Patients who self-report as African American, Non-Hispanic White
  • * Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor.
  • * Patient under 18 years of age
  • * Has no suspicion or diagnosis of a pancreatic cancer or tumor
  • * Self-reported race/ethnicity other than African American or Non-Hispanic White.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

H. Lee Moffitt Cancer Center and Research Institute,

Jennifer Permuth, PhD, MS, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Mokenge Malafa, MD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

2026-12